XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net loss $ (43,804,160) $ (7,652,100)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 97,242 70,279
Provision for bad debt 245,219 303,879
Stock based compensation expense 1,614,845 3,414,440
Goodwill impairment charge 37,093,047 0
Gain on debt forgiveness 0 (290,520)
Other (10,004) 4,673
Changes in assets and liabilities:    
Accounts receivable (890,880) (1,415,657)
Inventory (1,820,785) (3,198,877)
Inventory deposits (326,854) (4,503,079)
Prepaid expenses 325,638 693,375
Other current assets (156,457) 0
Other non-current assets 143,270 123,343
Accounts payable 365,284 (235,306)
Accrued liabilities (305,065) (10,229)
Other non-current liabilities (2,427) (240,976)
Net cash used in operating activities (7,432,087) (12,936,755)
Cash flows from investing activities:    
Purchase of property and equipment, net (168,583) (27,958)
Purchases of marketable securities (3,942,940) (16,233,213)
Proceeds from sales and maturities of marketable securities 9,619,242 8,210,000
Cash acquired in merger 0 3,373,332
Net cash provided by (used in) investing activities 5,507,719 (4,677,839)
Cash flows from financing activities:    
Proceeds from issuance of common stock 120,000 21,107,410
Payments for deferred offering costs 0 (188,015)
Principal advances from (repayments on) debt (276,690) (328,408)
Net cash (used in) provided by financing activities (156,690) 20,590,987
Net change in cash, restricted cash and cash equivalents (2,081,058) 2,976,393
Cash, restricted cash and cash equivalents at the beginning of the period 4,906,525 1,930,132
Cash, restricted cash and cash equivalents at the end of the period 2,825,467 4,906,525
Supplemental cash flow disclosures:    
Cash paid for interest expense 16,338 7,705
Cash paid for income taxes 0 2,400
Non-cash investing and financing activities:    
Common stock issued in litigation settlements accrued in 2022 322,431 0
Notes payable issued to finance prepaid insurance 439,087 0
Notes payable issued to finance purchase of property and equipment $ 25,007 $ 0